Top holdings
Name
Weight
18.13 %
12.86 %
5.93 %
5.85 %
5.77 %
5.75 %
5.35 %
5.17 %
4.68 %
3.94 %
3.50 %
3.44 %
3.36 %
3.07 %
2.91 %
2.64 %
1.73 %
1.47 %
1.40 %
0.51 %
0.45 %
0.38 %
0.32 %
0.27 %
0.26 %
0.25 %
0.24 %
0.21 %
0.10 %
0.07 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Analysis
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Top holdings
Name
Weight
18.13 %
12.86 %
5.93 %
5.85 %
5.77 %
5.75 %
5.35 %
5.17 %
4.68 %
3.94 %
3.50 %
3.44 %
3.36 %
3.07 %
2.91 %
2.64 %
1.73 %
1.47 %
1.40 %
0.51 %
0.45 %
0.38 %
0.32 %
0.27 %
0.26 %
0.25 %
0.24 %
0.21 %
0.10 %
0.07 %
Analyst ratings
FAQ
- What is THNR?
- Does THNR pay dividends?
- What stocks are in THNR?
- What is the current assets under management for THNR?
- What is THNR average volume?
- What is THNR expense ratio?
- What is THNR inception date?
What is THNR?
THNR ETF is an exchange-traded fund that focuses on companies involved in renewable energy and sustainable practices. It aims to provide investors with exposure to the growing green economy while promoting environmental sustainability. The fund is designed for those looking to invest in eco-friendly businesses.
Does THNR pay dividends?
Yes, the Amplify Weight Loss Drug & Treatment ETF does pays dividends, with
the most recent payment being
$0.22
per share. The last ex-dividend date was on December 30, 2024, and the next ex-dividend date has not been announced yet
What stocks are in THNR?
As of today, Amplify Weight Loss Drug & Treatment ETF inlcudes 30 holdings, with 15 of them being companies from 8 different countries and 2 sectors. The most weighted holdings are Eli Lilly and Company (18.13%), Novo Nordisk A/S (12.86%) and Roche Holding AG (5.93%)
What is the current assets under management for THNR?
Assets under management of Amplify Weight Loss Drug & Treatment ETF is $3 M
What is THNR average volume?
Average volume of Amplify Weight Loss Drug & Treatment ETF is $7357
What is THNR expense ratio?
Expense ratio of Amplify Weight Loss Drug & Treatment ETF is 0.59%
What is THNR inception date?
null